Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)-Reference-Cited by-同舟云学术

Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

Published:2015-06 Issue:6 Volume:67 Page:1028-1038
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

James Nicholas David,Spears Melissa R.,Clarke Noel W.,Dearnaley David P.,De Bono Johann S.,Gale Joanna,Hetherington John,Hoskin Peter J.,Jones Robert J.,Laing Robert,Lester Jason F.,McLaren Duncan,Parker Christopher C.,Parmar Mahesh K.B.,Ritchie Alastair W.S.,Russell J. Martin,Strebel Räto T.,Thalmann George N.,Mason Malcolm D.,Sydes Matthew R.

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial;Attard;Eur Urol,2014

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;De Bono;Lancet,2010

5. Abiraterone and increased survival in metastatic prostate cancer;De Bono;N Engl J Med,2011

Cited by 346 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Effects of Prostate Radiotherapy Intensified with Pelvic Nodal Radiotherapy and Androgen Deprivation Therapy on Myelosuppression: Single-Institution Experience;Current Oncology;2024-09-13

2. Comparative Analysis of PSA Nadir and Time to PSA Nadir on Clinical Outcomes in Patients with De Novo Spine Metastasis of Prostate Cancer Undergoing Androgen Deprivation Treatment (ADT) Only vs. ADT Intensification;annals of urologic oncology;2024-08-09

3. Lymph node oligometastases from prostate cancer: extensive or localized treatments - do we have a basis to decide?;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-12

4. The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-19

5. To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics;Frontiers in Pharmacology;2024-06-07